Skip to main content

Table 2 Classification of 52 analyzable ovarian cancer patients (see TableĀ 1) into three groups regarding the applied therapy

From: Prediction of clinical response to drugs in ovarian cancer using the chemotherapy resistance test (CTR-test)

Number Group name Description of therapy
16 Mono Patients received a monotherapy with one chemotherapeutic drug
3 (Mono) Patients received a monotherapy with one chemotherapeutic drug plus a treatment with Avastin
33 Combi Patients received a combination therapy with 2 drugs